L B Koppert
Overview
Explore the profile of L B Koppert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
379
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huberts A, Albers E, de Ligt K, Koppert L, Schagen S, van de Poll-Franse L
Eur J Oncol Nurs
. 2024 Sep;
72:102685.
PMID: 39288677
Purpose: This study investigated self-reported clinically relevant cognitive impairment of breast cancer patients in routine clinical care and assessed factors associated with new-onset clinically relevant cognitive impairment. Methods: Cognitive functioning...
2.
de Ligt K, Koppert L, de Rooij B, van de Poll-Franse L, Velikova G, Cardoso F
Breast
. 2024 Feb;
74:103676.
PMID: 38359564
The sustainability of healthcare systems is under pressure. Unlike care for many other chronic diseases, cancer care has yet to empower patients in effectively self-managing both the medical and emotional...
3.
Vrancken Peeters N, Kaplan Z, Clarijs M, Mureau M, Verhoef C, van Dalen T, et al.
Qual Life Res
. 2023 Oct;
33(2):467-479.
PMID: 37889384
Purpose: As life expectancy continues to rise, post-treatment health-related quality of life (HRQoL) of breast cancer patients becomes increasingly important. This study examined the one-year longitudinal relation between axillary treatments...
4.
de Ligt K, de Rooij B, Hedayati E, Karsten M, Smaardijk V, Velting M, et al.
Breast Cancer Res Treat
. 2023 Jan;
198(2):265-281.
PMID: 36662394
Purpose: For patients living with metastatic breast cancer (MBC), achieving best possible health-related quality of life, along with maximizing survival, is vital. Yet, we have no systemic way to determine...
5.
van Egdom L, de Ligt K, de Munck L, Koppert L, Mureau M, Rakhorst H, et al.
Breast Cancer
. 2021 Nov;
29(2):324-335.
PMID: 34780034
Purpose: Delayed breast reconstruction (DBR) is a valid option for postmastectomy breast cancer patients who have a desire for breast reconstruction but are not considered suitable for immediate breast reconstruction...
6.
Simons J, Koppert L, Luiten E, van der Pol C, Samiei S, de Wilt J, et al.
Breast Cancer Res Treat
. 2020 Mar;
180(3):725-733.
PMID: 32180074
Purpose: An overall trend is observed towards de-escalation of axillary surgery in patients with breast cancer. The objective of this study was to evaluate this trend in patients treated with...
7.
van Egdom L, de Kock M, Apon I, Mureau M, Verhoef C, Hazelzet J, et al.
Breast Cancer
. 2019 Dec;
27(3):426-434.
PMID: 31832891
Purpose: The aim of this study was to compare patient-reported outcomes (PROs) of BRCA1/2 mutation carriers, either after bilateral prophylactic mastectomy (BPM) or during breast surveillance, to improve shared decision-making...
8.
Simons J, Maaskant-Braat A, Luiten E, Leidenius M, van Nijnatten T, Boelens P, et al.
Eur J Surg Oncol
. 2019 Oct;
46(1):218-219.
PMID: 31662226
No abstract available.
9.
Simons J, van Pelt M, Marinelli A, Straver M, Zeillemaker A, Pereira Arias-Bouda L, et al.
Br J Surg
. 2019 Oct;
106(12):1632-1639.
PMID: 31593294
Background: Marking the axilla with radioactive iodine seed and sentinel lymph node (SLN) biopsy have been proposed for axillary staging after neoadjuvant systemic therapy in clinically node-positive breast cancer. This...
10.
Simons J, Maaskant-Braat A, Luiten E, Leidenius M, van Nijnatten T, Boelens P, et al.
Eur J Surg Oncol
. 2019 Aug;
46(1):53-58.
PMID: 31434617
Introduction: Various options for axillary staging after neoadjuvant systemic therapy (NST) are available for breast cancer patients with a clinically positive axillary node (cN+). This survey assessed current practices amongst...